Category Archives: Cancer

A Closer look at Mikhail Blagosklonny

Mikhail Blagosklonny is a well known and accomplished Scientist that has devoted his career and profession to the study of Aging as well as Cancer. Presently, Mikhail Blagosklonny is on staff as a Professor of Oncology at Roswell Park Cancer Institute. The Roswell Cancer Institute is located in New York.

*Educational Background/ Area of Concentration:

Mikhail Blagosklonny graduated from the First Pavlov State Medical University. The University is located within the Saint Pettersburg area of Florida. Mikhail Blagosklonny received both is MD as well as his PHD from First Pavlov Medical University. His primary area of study was on Experimental Medicine techniques as well as studies involving the heart and circulatory system (Cardiology).

Part of Mikhail Blagosklonny work experience involves being appointed Associate Professor of Medicine at New York Medical College. It was during his tenure with New York Medical College that the Doctor developed an interest in researching as well as studying Cancer and the aging process.

After his experience as Associate Professor of Medicine, Mikhail Blagosklonny accepted a position as a Research Scientist at the Ordway Scientific and Research Institute. Blagosklonny became involved in various research projects while at Ordway. He held the position as Associate Professor of Medicine at Ordway Institute for a period of seven years.

After resigning from Ordway, Mikhail Blagosklonny accepted a position as Professor of Oncology at the Roswell Cancer Institute. Dr. Blagosklonny began intensive research which involved Cancer studies. In addition, Mikhail Blagosklonny began to research the aging process and the possibility of altering or slowing the process of aging. His studies seemed to both fascinate as well as intrigue staff members.

Mikhail Blagosklonny main area of study was on Cancer treatments that left healthy cell unharmed. In addition, his fascination with turning back the hands of time as far as aging was concerned seemed to dominate his research ideas and studies. Dr. Blagosklonny discovered that TOR Signaling played a definite role in the aging process.

*Anti-aging Studies/ Publications:

During the course of Mikhail Blagosklonny’s anti-aging studies he discovered that the drug Rapamycin could possibly extend ones life dramatically. Rapamycin was commonly used as a Cancer drug however, Dr. Blagosklonny felt it could be useful in reversing as well as altering the process of aging. He is a firm believer that Rapamycin should be used in research studies involving longevity and anti-aging. However, as expected Mikhail Blagosklonny received much opposition for his research ideas for a variety of reasons.

Mikhail Blagosklonny has written several medical publications. In addition, he has co-authored the books “Cell Cycle” as well as “Cancer Biology & Therapy”. He is also a regular member of the Medical Editorial Board of “Cell Death and Differentiation”. Dr. Blagosklonny has also spoken at several medical conferences on a national level.

Eric Lefkofsky – Taking Charge of Cancer with Modern Technology

Almost 40 percent adults in the United States face a diagnosis of cancer at some stage in their lives. According to NCI (National Cancer Institute), roughly 14.5 million citizens of United States had cancer in the year 2014. The number is expected to be over 19 million by 2024. Thanks to advances that are made by companies such as Temper, the forecast seems better. Tempus leads the charge in precision medicine that are data enabled. The health industry is up to speed with the modern health care technology.

Eric Lefkofsky, the founder of Tempus never had a personal experience with treatment of cancer, until his spouse was diagnosed with breast cancer. He got shocked when he learned about the gaping hole existing in the field regarding digital technology and data collection. Despite the amount of data collected and generated by patients and their treatments, there’s no streamlined, effective way to collect that information and use it effectively.

That’s why Tempus came into play. The company had an impressive and lofty goal of transforming how cancer care delivered. Tempus developed a platform that analyzes molecular and clinical data of patients. It had means of developing analytics software but had some issues.

Eric Lefkofsky was born on Sept. 2, 1969. He’s an entrepreneur from the U.S. He’s the CEO and co-founder of Tempus. He’s also the chairman and co-founder of Groupon. He co-founded ECHO (Echo Global Logistics), INWK(InnerWorkings), Uptake, and Mediaocean. Lefkofsky is the co founder of venture capital (VC) firm, Lightbank. He studied at University of Michigan (UM), where he graduated cum laude in the year 1991. He continued studying at Michigan Law, where he received his Juris Doctor in the year 1993.

Lefkofsky with his wife Liz established Lefkofsky Family Foundation in 2006, which is a private charitable foundation, meant to advance initiatives that are of high impact that improves lives in communities that are served. Lefkofsky works as Trustee for World Business Chicago, MSI (Museum of Science and Industry), and The Art Institute of Chicago. He’s an adjunct lecturer at U of C and Accelerated Disruption author.

To know more visit @: https://www.tempus.com/about-us/